# Fibrosis and the Fontan

> **NCT04901975** · PHASE1,PHASE2 · RECRUITING · sponsor: **Children's Hospital of Philadelphia** · enrollment: 145 (estimated)

## Conditions studied

- Single-ventricle

## Interventions

- **DRUG:** Spironolactone

## Key facts

- **NCT ID:** NCT04901975
- **Lead sponsor:** Children's Hospital of Philadelphia
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2021-02-11
- **Primary completion:** 2026-06-30
- **Final completion:** 2026-06-30
- **Target enrollment:** 145 (ESTIMATED)
- **Last updated:** 2025-06-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04901975

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04901975, "Fibrosis and the Fontan". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT04901975. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*